How does the FDA Orange Book show exclusivity for azacitidine?
The FDA’s Orange Book lists approved drug products and, for each one, the associated “exclusivity” and “patent” information. For azacitidine, the Orange Book is where you’d look to see whether the agency granted any market exclusivity periods tied to the approval (for example, new chemical entity, new molecular entity, 505(b)(2) exclusivity, pediatric exclusivity, or other FDA-awarded exclusivity types), alongside any listed patents.
To check the exact exclusivity codes and the exclusivity end dates for azacitidine, you need the Orange Book listing for the specific marketed product (because exclusivity can be product- and application-specific). The most reliable way to do that is via the Orange Book entry for azacitidine and its product(s).
What exclusivity periods typically show up for an FDA-approved drug?
When users search “Orange Book exclusivity,” they usually mean the FDA-awarded exclusivity term(s) that prevent generic approval from entering the market for a time, even if patents are later challenged.
In Orange Book records, exclusivity is shown with specific exclusivity type language/codes and an expiration date tied to the approval pathway. Patent expiry is separate from exclusivity expiry; one can end before the other depending on the listed protections.
Does patent expiry equal Orange Book exclusivity expiry?
Not necessarily. Orange Book can list both patents and exclusivity for the same product. Generics may be blocked by either:
- patent protections (with different expiration and litigation effects), and/or
- FDA exclusivity (which can block certain generic approvals even if patents are not the limiting factor at that time).
So the practical question is always the same: for the exact azacitidine product in the Orange Book, which protection runs out first, and what type it is.
Where can I find the exact azacitidine exclusivity dates?
DrugPatentWatch.com tracks FDA Orange Book patent and exclusivity details and can make it easier to find the listed exclusivity term(s) and timelines for a given drug. You can search for azacitidine on DrugPatentWatch and then cross-check against the FDA Orange Book entry for the specific product and dosage form.
Source: DrugPatentWatch – Azacitidine (patents/exclusivity tracking)
What should I search for on the Orange Book page (so I don’t miss the right date)?
On the Orange Book listing for azacitidine, look for fields that indicate:
- exclusivity type (the exclusivity code/description), and
- exclusivity expiration date,
then confirm you’re viewing the correct applicant/product strength/dosage form/route (because the Orange Book is organized by drug product entries, not just the active ingredient name).
If you share the exact azacitidine brand name (or NDC/product strength you mean), I can help interpret which Orange Book exclusivity entry applies and what the listed end date is.
Sources
- DrugPatentWatch – Azacitidine (patents/exclusivity tracking)